October 7, 2024
TOPLINE: Older adults with antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis face a higher risk for end-stage renal disease or mortality and severe infections. However, frailty, more than […]
October 7, 2024
TOPLINE: Crisugabalin — an oral calcium channel alpha 2 delta-1 subunit ligand — was safe and well-tolerated at doses of 40 mg/d and 80 mg/d and […]
October 7, 2024
TOPLINE: Eczematous dermatitis, folliculitis, and seborrheic dermatitis were the most common skin conditions in patients with Down syndrome (DS) in a 10-year retrospective review. METHODOLOGY: Researchers […]
October 4, 2024
TOPLINE: Patients with inflammatory rheumatic diseases who are systematically screened for common chronic and preventable diseases are more likely to receive preventive medications and less likely […]
October 4, 2024
TOPLINE: Erenumab, injected monthly at 140 mg, can effectively induce remission of nonopioid medication overuse headache (MOH) in patients with chronic migraine within 6 months. The […]
October 4, 2024
TOPLINE: Prehospital opioid overdoses among young people increased sharply during the COVID-19 pandemic, with 86.7% cases occurring in young adults aged 18-24 years, a new study […]
October 4, 2024
TOPLINE: Temtokibart, a novel monoclonal antibody, appears to achieve clinical improvements in moderate to severe atopic dermatitis (AD) by normalizing the skin barrier and increasing hydration, […]
October 4, 2024
TOPLINE: Older adults who experience falls are at a higher risk of developing dementia within a year. The study found that 10.6% of patients who fell […]
October 4, 2024
TOPLINE: Long-term exposure to air pollution, particularly particulate matter between 2.5 and 10 μm in diameter (PM10-2.5), is associated with a higher risk of developing physical […]